Quant Guide 2021: Fordham University

New York City, US

Fordham University
 

 

Fordham University’s Master of Science in Quantitative Finance (MSQF), taught at the Gabelli School of Business, has added a significant number of new teaching staff in the past year. There are now a full 20 instructors on the MSQF, 10 of whom have an industry affiliation. That’s a significant increase compared with 16 teaching staff last year, eight of whom were industry-affiliated.

The programme has experienced, like many others in this year’s Quant Guide, a large number of coronavirus-related deferrals this year. Its intake in the previous iteration of the guide was 74, while this year’s cohort numbers 31. More applications were received this year, however – 466, compared with last year’s 440 – and more offers were extended, too. 64 students accepted their offers, while 31 enrolled – suggesting the programme’s next intake will be substantially larger.

More favourably, smaller class sizes and more instructors means the contact time students should expect with faculty has also been boosted, for a total of 675 hours across the whole degree, which can be completed in one to two years.

Coronavirus measures reported by the programme include: cutting down physical class sizes; a new heating, ventilation and air conditioning system to improve air circulation; and a regime of frequent testing for those who do attend campus. So far, however, a majority of students have kept away from the classroom: the programme reports that 80% of teaching has been conducted remotely throughout the autumn semester.

View this institution’s entry in the 2020 guide

View other universities and a guide to the metrics tables

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here